Holger Laux | Fellow
Novartis Pharma

Holger Laux, Fellow, Novartis Pharma

Dr. Laux is leading the mammalian expression platform of Technical Development NBE unit, Novartis Basel. Throughout his career he focused his work on functional genomics approaches as transcriptomics screens and subsequently cell line engineering editing. These efforts resulted in generation of several improved CHO production cell lines. He was also supporting the sequencing of Chinese hamster resulting in a public available Chinese hamster genome. He is additionally involved in enabling and improving the production of difficult to express therapeutic recombinant proteins

Appearances:



Advanced Therapies and Regenerative Medicine Day 2 - Thursday 17th May 2018 @ 11:40

Generation of superior host cell lines for biomanufacturing

back to speakers

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com